全文获取类型
收费全文 | 26902篇 |
免费 | 1805篇 |
国内免费 | 82篇 |
专业分类
耳鼻咽喉 | 229篇 |
儿科学 | 660篇 |
妇产科学 | 460篇 |
基础医学 | 3945篇 |
口腔科学 | 341篇 |
临床医学 | 2535篇 |
内科学 | 6518篇 |
皮肤病学 | 681篇 |
神经病学 | 2250篇 |
特种医学 | 818篇 |
外国民族医学 | 3篇 |
外科学 | 3914篇 |
综合类 | 287篇 |
一般理论 | 28篇 |
预防医学 | 2016篇 |
眼科学 | 513篇 |
药学 | 1651篇 |
1篇 | |
中国医学 | 56篇 |
肿瘤学 | 1883篇 |
出版年
2022年 | 144篇 |
2021年 | 359篇 |
2020年 | 237篇 |
2019年 | 368篇 |
2018年 | 444篇 |
2017年 | 300篇 |
2016年 | 366篇 |
2015年 | 430篇 |
2014年 | 642篇 |
2013年 | 977篇 |
2012年 | 1428篇 |
2011年 | 1594篇 |
2010年 | 968篇 |
2009年 | 976篇 |
2008年 | 1529篇 |
2007年 | 1685篇 |
2006年 | 1672篇 |
2005年 | 1770篇 |
2004年 | 1625篇 |
2003年 | 1547篇 |
2002年 | 1546篇 |
2001年 | 418篇 |
2000年 | 363篇 |
1999年 | 413篇 |
1998年 | 390篇 |
1997年 | 342篇 |
1996年 | 299篇 |
1995年 | 282篇 |
1994年 | 259篇 |
1993年 | 235篇 |
1992年 | 328篇 |
1991年 | 301篇 |
1990年 | 286篇 |
1989年 | 266篇 |
1988年 | 236篇 |
1987年 | 230篇 |
1986年 | 237篇 |
1985年 | 231篇 |
1984年 | 213篇 |
1983年 | 208篇 |
1982年 | 227篇 |
1981年 | 234篇 |
1980年 | 192篇 |
1979年 | 149篇 |
1978年 | 136篇 |
1977年 | 138篇 |
1976年 | 119篇 |
1975年 | 113篇 |
1974年 | 104篇 |
1973年 | 98篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
101.
Elke Wezenberg Robert Jan Verkes Ge S F Ruigt Wouter Hulstijn Bernard G C Sabbe 《Neuropsychopharmacology》2007,32(6):1272-1283
Ampakines act as positive allosteric modulators of AMPA-type glutamate receptors and facilitate hippocampal long-term potentiation (LTP), a mechanism associated with memory storage and consolidation. The present study investigated the acute effects of farampator, 1-(benzofurazan-5-ylcarbonyl) piperidine, on memory and information processes in healthy elderly volunteers. A double-blind, placebo-controlled, randomized, cross-over study was performed in 16 healthy, elderly volunteers (eight male, eight female; mean age 66.1, SD 4.5 years). All subjects received farampator (500 mg) and placebo. Testing took place 1 h after drug intake, which was around Tmax for farampator. Subjects performed tasks assessing episodic memory (wordlist learning and picture memory), working and short-term memory (N-back, symbol recall) and motor learning (maze task, pursuit rotor). Information processing was assessed with a tangled lines task, the symbol digit substitution test (SDST) and the continuous trail making test (CTMT). Farampator (500 mg) unequivocally improved short-term memory but appeared to impair episodic memory. Furthermore, it tended to decrease the number of switching errors in the CTMT. Drug-induced side effects (SEs) included headache, somnolence and nausea. Subjects with SEs had significantly higher plasma levels of farampator than subjects without SEs. Additional analyses revealed that in the farampator condition the group without SEs showed a significantly superior memory performance relative to the group with SEs. The positive results on short-term memory and the favorable trends in the trail making test (CTMT) are interesting in view of the development of ampakines in the treatment of Alzheimer's disease and schizophrenia. 相似文献
102.
A unique example of a gingival salivary gland choristoma together with a gingival cyst is described in a human autopsy specimen of periodontal tissues. A choristoma is a tumor-like growth which is derived from primordial cells which have been displaced from their original tissue or organ. Only 6 other examples of the gingival salivary gland choristoma have been described in the world literature. 相似文献
103.
104.
Eduardo Martínez-Soria Viktor Steimle Charlotte Burkhardt Pascale Beffy Jean-Marie Tiercy Jrg T. Epplen Bernard Mach Claude Irl 《Human immunology》1994,40(4)
The T-cell recognition of HLA-DR-peptide complexes is generally restricted by the polymorphism of the DRB molecules but pluriallelic restriction has been described. The molecular basis of restriction and promiscuity of such peptide-specific responses is poorly understood. We isolated a panel of T-cell lines specific for the tetanus toxin peptide p2 (TT830-843) exhibiting pluriallelic restriction by DR11 and DR8 alleles. Fine restriction specificity of the T-cell lines was examined in functional assays against DR oligotyped APCs expressing different variants of DR11 and DR8 alleles. Our results show that (a) polymorphisms between serologically related alleles are relevant in terms of restriction of the peptide-specific T-cell response; in some instances, a single amino acid substitution can determine the restriction of a T-cell line; (b) different patterns of restriction are not the result of specific differences in DR-p2 binding as p2 peptide binds to all DR11 and DR8 alleles tested (DRB1* 1101, -1102, -1103, -1104, 110X, -0801, -0802, -0803, and -0806); and (c) pluriallelic restriction of the peptide-specific T-cell responses correlates with the presence of a DRB1 α-helix motif (67-71-86) shared by some DR11 and DR8 alleles. Possible implications of pluriallelic restriction of peptide-specific T-cell response in autoimmune disorders associated with DR11 and DR8 are discussed. 相似文献
105.
Marsha Bernard Kuhar 《AAOHN journal》2002,50(8):360-364
1. The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATPIII) will significantly increase the number of Americans treated for hypercholesterolemia. 2. The ATPIII focuses on lowering low density lipoprotein cholesterol as a primary initiative and using exercise, diet, and pharmacotherapy as a means for lowering coronary heart disease and risks. 3. The new guidelines list low density lipoprotein cholesterol levels of less than 100 mg/dL as optimal for all clients. 4. The ATPIII places increased attention on high triglyceride levels (> 200 mg/dL) and on early detection and appropriate aggressive treatment for clients at risk for coronary heart disease and events. 相似文献
106.
Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. 总被引:1,自引:0,他引:1
Evelyne Vinet Pierre Perreault Louis Bouchard Denis Bernard Ramses Wassef Carole Richard Richard Létourneau Gilles Pomier-Layrargues 《Journal canadien de gastroenterologie》2006,20(6):401-404
Surgery in cirrhotic patients is associated with high morbidity and mortality related to portal hypertension and liver insufficiency. Therefore, preoperative portal decompression is a logical approach to facilitate abdominal surgery and hopefully to improve postoperative survival. The present study evaluated the clinical outcomes of 18 patients (mean age 58 years) with cirrhosis (seven alcoholics and 11 nonalcoholics) who underwent transjugular intrahepatic portosystemic shunt (TIPS) placement before antrectomy (n=5), colectomy (n=10), small-bowel resection (n=1), pancreatectomy (n=1) and nephrectomy (n=1). TIPS was performed a mean (+/-SD) of 72+/-21 days before surgery and induced a marked mean decrease in portohepatic gradient from 21.4+/-3.9 mmHg to 8.4+/-3.4 mmHg. Cirrhotic patients (n=17) who underwent elective abdominal surgery without preoperative TIPS placement were used as the control group. Both groups were matched for age, etiology of cirrhosis, indications for surgery, type of surgery and coagulation parameters. The mean Pugh score was significantly higher in the TIPS group (7.7 versus 6.2). No significant differences were observed for operative blood loss, postoperative complications, duration of hospitalization and one-month (83% versus 88%) or one-year (54% versus 63%) cumulative survival rate. Analysis using the Cox proportional hazards model showed that neither TIPS placement nor preoperative Pugh score were independent predictors for survival. The present study suggests that preoperative TIPS placement does not improve postoperative evolution after abdominal surgery in cirrhotic patients with good or moderately impaired liver function. 相似文献
107.
108.
Marko Simunovic Eddy Rempel Marc-Erick Thériault Angela Coates Timothy Whelan Eric Holowaty Bernard Langer Mark Levine 《Canadian journal of surgery》2006,49(4):251-258
BACKGROUND: There is a lack of information from Canadian hospitals on the role of hospital characteristics such as procedure volume and teaching status on the survival of patients who undergo major cancer resection. Therefore, we chose to study these relationships using data from patients treated in Ontario hospitals. METHODS: We used the Ontario Cancer Registry from calendar years 1990-2000 to obtain data on patients who underwent surgery for breast, colon, lung or esophageal cancer or who underwent major liver surgery related to a cancer diagnosis between 1990 and 1995 in order to assess the influence of volume of procedures and teaching status of hospitals on in-hospital death rate and long-term survival. For each disease site and before observing patient outcomes data, volume cut-off points were selected to create volume groups with similar numbers of patients. Teaching hospitals were those directly affiliated with a medical school. Logistic regression and proportional hazards models were used to consider the clustering of data at the hospital level and to assess operative death and long-term survival. We also used 4 measures to gauge the degree of procedure regionalization across the province including (1) the number of hospitals performing a procedure; (2) the percentage of patients treated in teaching hospitals; (3) the percentage of rural patients treated in higher volume procedure hospitals; and (4) median distances travelled by patients to receive care. RESULTS: The number of patients in our cohorts who underwent resection of the breast, colon, lung, esophagus or liver was 14 346, 8398, 2698, 629 and 362, respectively. Surgery in a high-volume versus a low-volume hospital did not have a statistically significant influence on the odds of operative death for patients who underwent colon, liver, lung or esophageal cancer resection. The risk of long-term death was increased in low-volume versus high-volume hospitals for patients who underwent resection of the breast (hazard ratio [HR] 1.2, 95% confidence interval [95% CI] 1.0-1.4, p < 0.05), lung (HR 1.3, 95% CI 1.1-1.6, p < 0.01) and liver (HR 1.7, 95% CI 1.0-2.7, p = 0.04). There were no significant differences in the odds of operative (in-hospital) death or risk of long-term death among patients treated in teaching compared with nonteaching hospitals. There was more regionalization of liver, lung and esophageal operations versus breast and colon operations. CONCLUSIONS: Increased hospital procedure volume correlated with improved longterm survival for patients in Ontario who underwent some, but not all, cancer resections, whereas hospital teaching status had no significant impact on patient outcomes. Across the province, further regionalization of care may help improve the quality of some cancer procedures. 相似文献
109.
John M. H. de Klerk Bernard A. Zonnenberg Alfred D. van het Schip Aalt van Dijk Shiuw H. Han Jacques M. S. R. Quirijnen Geert H. Blijham Peter R van Rijk 《European journal of nuclear medicine and molecular imaging》1994,21(10):1114-1120
Rhenium-186 hydroxyethylidene diphosphonate (186Re-HEDP) has been used for the palliative treatment of metastatic bone pain. A phase 1 dose escalation study was performed using 186Re-HEDP Twenty-four patients with hormone-resistant prostate cancer entered the study. Each patient had at least four bone metastases and adequate haematological function. Groups of at least three consecutive patients were treated with doses starting at 1295 MBq and increasing to 3515 MBq (escalated in increments of 555 MBq). Thrombocytopenia proved to be the dose-limiting toxicity, while leucopenia played a minor role. Early death occurred in one patient (10 days after administration) without clear relationship to the 186Re-HEDP therapy. Transient neurological dysfunction was seen in two cases. Two patients who received 3515 MBq 186Re-HEDP showed grade 3 toxicity (thrombocytes 25–50 × 109/1), defined as unacceptable toxicity. After treatment alkaline phosphatase levels showed a transient decrease in all patients (mean: 26% ± 10% IUA; range: 11%–44%). Prostate-specific antigen values showed a decline in eight patients, preceded by a temporary increase in three patients. From this study we conclude that the maximally tolerated dose of 186Re-HEDP is 2960 MBq. A placebo-controlled comparative study on the efficacy of 186Re-HEDP has been initiated. 相似文献
110.